Multilevel Predictors of Telehealth and Medicaid Payment Acceptance in Substance Use Treatment Facilities: Stronger State Policy Associations in Rural Communities, US, 2024
The Journal of Rural Health · 2026-09 · 42 (4)
DOI: 10.1111/jrh.70244 ↗Abstract
ABSTRACT Purpose To test whether the association between Medicaid telehealth policies and availability of telehealth + Medicaid payment acceptance in substance use treatment settings varied as a function of rurality. Methods We used the Mental Health and Addiction Treatment Tracking Repository to identify all known licensed outpatient substance use treatment facilities in the United States (2023; N = 10,537 facilities). We used multiple logistic regression to model whether a treatment facility offered telehealth and accepted Medicaid as payment. We included several interaction terms to test whether the association between state Medicaid policies and telehealth + Medicaid payment acceptance was conditional on the percentage of a census tract that was rural. Findings Two‐thirds of outpatient treatment facilities (67%) offered telehealth and accepted Medicaid as payment. Among facilities in states with no Medicaid originating site restrictions, the predicted probability of offering telehealth + Medicaid payment acceptance increased from roughly 70% in areas with very small rural populations to over 85% in areas with very large rural populations (interaction p < 0.0001). A similar pattern emerged among facilities in states where Medicaid reimburses for transmission and facility fees (interaction p < 0.01). Conclusions State Medicaid policies that do not restrict originating sites and reimburse for transmission fees were more strongly associated with treatment facilities offering telehealth and accepting Medicaid payments in more rural areas. This finding that some Medicaid telehealth policies are more effective in rural than in urban areas suggests that differences between rural and urban health systems are substantial, and that state policies may not work as one‐size‐fits‐all.
EUVIMED